Literature DB >> 23001293

Overexpression of p53 protein in human tumors.

Keiji Inoue1, Atsushi Kurabayashi, Taro Shuin, Yuji Ohtsuki, Mutsuo Furihata.   

Abstract

According to the current concept of carcinogenesis, neoplastic transformation consists of multistep accumulations of adverse genetic and epigenetic events. p53 is a transcription factor that regulates cellular response to diverse forms of stress through a complex network which monitors genome integrity and cell homeostasis. Mutant p53 loss-of-function, dominant-negative, and gain-of-function properties have been implicated in the development of a wide variety of human cancers, and it is generally accepted that p53 is a component in biochemical pathways central to human carcinogenesis. Study of p53 has come to the forefront of cancer research, and detection of its abnormalities during the development of tumors may have diagnostic, prognostic, and therapeutic implications. In this review, we focus on recent research on overexpression of mutant p53 in human cancer, with an emphasis on mutant p53 regulation, gain of function of mutant p53 in transcriptional effects, and the diagnostic, prognostic, and predictive value of p53 overexpression in human cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23001293     DOI: 10.1007/s00795-012-0575-6

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  110 in total

Review 1.  Transcriptional regulation by p53: one protein, many possibilities.

Authors:  O Laptenko; C Prives
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

2.  Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene.

Authors:  L Raycroft; H Y Wu; G Lozano
Journal:  Science       Date:  1990-08-31       Impact factor: 47.728

3.  Localization of gene for human p53 tumour antigen to band 17p13.

Authors:  M Isobe; B S Emanuel; D Givol; M Oren; C M Croce
Journal:  Nature       Date:  1986 Mar 6-12       Impact factor: 49.962

4.  The aberrant p53 protein (review).

Authors:  M Furihata; H Sonobe; Y Ohtsuki
Journal:  Int J Oncol       Date:  1995-06       Impact factor: 5.650

5.  Wild type human p53 is antiproliferative in SV40-transformed hamster cells.

Authors:  W E Mercer; M Amin; G J Sauve; E Appella; S J Ullrich; J W Romano
Journal:  Oncogene       Date:  1990-07       Impact factor: 9.867

6.  Clonal analysis of human colorectal tumors.

Authors:  E R Fearon; S R Hamilton; B Vogelstein
Journal:  Science       Date:  1987-10-09       Impact factor: 47.728

Review 7.  TP53 tumor suppressor gene: a model for investigating human mutagenesis.

Authors:  C Caron de Fromentel; T Soussi
Journal:  Genes Chromosomes Cancer       Date:  1992-01       Impact factor: 5.006

8.  Both germ line and somatic genetics of the p53 pathway affect ovarian cancer incidence and survival.

Authors:  Frank Bartel; Juliane Jung; Anja Böhnke; Elise Gradhand; Katharina Zeng; Christoph Thomssen; Steffen Hauptmann
Journal:  Clin Cancer Res       Date:  2008-01-01       Impact factor: 12.531

9.  Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome.

Authors:  J M Birch; V Blair; A M Kelsey; D G Evans; M Harris; K J Tricker; J M Varley
Journal:  Oncogene       Date:  1998-09-03       Impact factor: 9.867

10.  Increased expression of mutant forms of p53 oncogene in primary lung cancer.

Authors:  R Iggo; K Gatter; J Bartek; D Lane; A L Harris
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

View more
  14 in total

Review 1.  Translational research in pancreatic ductal adenocarcinoma: current evidence and future concepts.

Authors:  Stephan Kruger; Michael Haas; Steffen Ormanns; Sibylle Bächmann; Jens T Siveke; Thomas Kirchner; Volker Heinemann; Stefan Boeck
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Dietary diindolylmethane suppresses inflammation-driven lung squamous cell carcinoma in mice.

Authors:  Jung Min Song; Xuemin Qian; Fitsum Teferi; Jing Pan; Yian Wang; Fekadu Kassie
Journal:  Cancer Prev Res (Phila)       Date:  2014-11-17

3.  Association of p53 expression with prognosis in patients with esophageal squamous cell carcinoma.

Authors:  Wenjian Yao; Xiuguang Qin; Bo Qi; Jianguo Lu; Ling Guo; Fulei Liu; Shangguo Liu; Baosheng Zhao
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

4.  Association of p53 and p21 polymorphisms with prostate cancer.

Authors:  Monika Kmeťová Sivoňová; Marta Vilčková; Ján Kliment; Silvia Mahmood; Jana Jurečeková; Svetlana Dušenková; Iveta Waczulíková; Peter Slezák; Dušan Dobrota
Journal:  Biomed Rep       Date:  2015-07-27

5.  The protein p17 signaling pathways in cancer.

Authors:  Klaus Heese
Journal:  Tumour Biol       Date:  2013-07-31

6.  In situ normoxia enhances survival and proliferation rate of human adipose tissue-derived stromal cells without increasing the risk of tumourigenesis.

Authors:  Jane Ru Choi; Belinda Pingguan-Murphy; Wan Abu Bakar Wan Abas; Kar Wey Yong; Chi Tat Poon; Mat Adenan Noor Azmi; Siti Zawiah Omar; Kien Hui Chua; Feng Xu; Wan Kamarul Zaman Wan Safwani
Journal:  PLoS One       Date:  2015-01-23       Impact factor: 3.240

7.  Expression and functions of galectin-7 in ovarian cancer.

Authors:  Marilyne Labrie; Maria Claudia Vladoiu; Andrée-Anne Grosset; Louis Gaboury; Yves St-Pierre
Journal:  Oncotarget       Date:  2014-09-15

Review 8.  Pulmonary oxidative stress, inflammation and cancer: respirable particulate matter, fibrous dusts and ozone as major causes of lung carcinogenesis through reactive oxygen species mechanisms.

Authors:  Athanasios Valavanidis; Thomais Vlachogianni; Konstantinos Fiotakis; Spyridon Loridas
Journal:  Int J Environ Res Public Health       Date:  2013-08-27       Impact factor: 3.390

9.  pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104.

Authors:  Steffen Ormanns; Jens T Siveke; Volker Heinemann; Michael Haas; Bence Sipos; Anna Melissa Schlitter; Irene Esposito; Andreas Jung; Rüdiger P Laubender; Stephan Kruger; Ursula Vehling-Kaiser; Cornelia Winkelmann; Ludwig Fischer von Weikersthal; Michael R Clemens; Thomas C Gauler; Angela Märten; Michael Geissler; Tim F Greten; Thomas Kirchner; Stefan Boeck
Journal:  BMC Cancer       Date:  2014-08-28       Impact factor: 4.430

10.  p53 expression in patients with ulcerative colitis - associated with dysplasia and carcinoma: a systematic meta-analysis.

Authors:  Xiaohong Lu; Yuanjie Yu; Shiyun Tan
Journal:  BMC Gastroenterol       Date:  2017-10-25       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.